Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspects.

about

Genetic variation and pharmacogenomics: concepts, facts, and challenges.Treatment goals: response and nonresponse Usefulness of Pharmacogenetic Analysis in Psychiatric Clinical Practice: A Case Report

P2860

Q35236771-59EAFFA4-C69B-4110-9DD8-E7E42F025545 Q38580554-918CD054-120F-4542-9906-EB5A2A2A9D5A Q58781437-C880EF78-43D5-49C1-AB99-DD2789DD9D37

P2860

Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspects.

Item

http://www.wikidata.org/entity/Q38580522

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspects.

@en

type

Item

label

Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspects.

@en

prefLabel

Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspects.

@en

P1476

Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspects

@en

P2093

Klaus Weber

http://www.w3.org/2001/XMLSchema#string

Manfred Ackenheil

http://www.w3.org/2001/XMLSchema#string

P2860

Dopamine D3 receptor gene: organization, transcript variants, and polymorphism associated with schizophrenia

Cytochrome P450-mediated drug interactions.

Neurotransmitter-related genes and antipsychotic response: pharmacogenetics meets psychiatric treatment.

Happy birthday neuroleptics! 50 years later: la folie du doute.

Studies on the conversion of haloperidol and its tetrahydropyridine dehydration product to potentially neurotoxic pyridinium metabolites by human liver microsomes.

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population: phenotypic-genotypic correlates.

P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.

"It's the genes, stupid". Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphism.

Clinical and neuropathological abnormalities in baboons treated with HPTP, the tetrahydropyridine analog of haloperidol.

P304

71-77

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22034253

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics

schizophrenia

P932

3181786

http://www.w3.org/2001/XMLSchema#string

Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspects.

about

P2860

P2860

Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspects.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932